Prima Biomed (PRR)
Chart: Share price over the year to versus ASX200 (XJO)
PRR focuses on developing anti-cancer therapeutics based on the emerging technology of immunotherapy. The technology is interesting in that it uses the body’s own processes to destroy cancer cells, reducing the side-effects compared to external chemotherapy agents. There’s several potential near-term catalysts for the stock, including the successful conclusion of clinical trials. Any good news should be positive for the share price.
http://www.thebull.com.au/premium/a/27776-18-share-tips---30-april-2012.html
Prima Biomed (PRR)Chart: Share price over the year to versus...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |